Biotech Values

[Swick984]

NCNA - I was curious if anyone had a view on NuCana and their ProTide platform. The share price has been steadily moving lower after a quick upturn post-IPO. The enterprise value is currently in the $250 million range. Their initial investors include Alida, Morningside and Sofinnova and some bought additional as part of the IPO. Their early clinical results look interesting and they seem to have built a better mousetrap using already approved compounds. Analysts came out and put targets in the mid $20's and higher last week. I'm curious if anyone here has taken a look at NCNA.

Thanks in advance.